Anionic amino acid-derived cationic lipid for siRNA delivery

Journal of Controlled Release

Volumn 140, Issue 3, 2009, Pages 268-276

  Suh, Min Sung ^a   Shim, Gayong ^a   Lee, Han Young ^a   Han, Su Eun ^a   Yu, Yong Hee ^a   Choi, Yongseok ^a   Kim, Kwangmeyung ^b   Kwon, Ick Chan ^b   Weon, Kwon Yeon ^c   Kim, Young Bong ^d   Oh, Yu Kyoung ^a  

^a Korea University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Handok Research Center   (South Korea)

^d Konkuk University   (South Korea)

Author keywords

Cationic lipid; Gene reduction; Liposome; siRNA; Viability

Indexed keywords

AFTER-TREATMENT; AMINO ACID DERIVATIVES; CARBAMOYL; CARBOXYLIC ACID GROUPS; CATIONIC LIPIDS; CATIONIC LIPOSOMES; CELLULAR DELIVERY; CONCURRENT DEVELOPMENT; GEL-RETARDATION ASSAY; GENE REDUCTION; GLUTAMIC ACID; HUMAN CANCER CELLS; IN-CELL; IN-VIVO; INTRATUMORAL INJECTION; LIPOFECTAMINE; LIPOPLEXES; LOCAL DELIVERY; MEAN INTENSITY; MOLECULAR IMAGING; MRNA LEVEL; OLEYLAMINE; PEPTIDE BONDS; RED FLUORESCENT PROTEINS; SAFE DELIVERY SYSTEMS; SIRNA DELIVERY; SURVIVIN; THERAPEUTIC STRATEGY; TUMOR TISSUES;

AMINATION; AMINES; AMINO ACIDS; CARBOXYLIC ACIDS; CELL CULTURE; DYES; FLUORESCENCE; FLUORINE CONTAINING POLYMERS; GALERKIN METHODS; ORGANIC ACIDS; PHOSPHOLIPIDS; RNA; STRATEGIC PLANNING; SYNTHESIS (CHEMICAL);

LIPOSOMES;

3BETA [N, (N',N' DIMETHYLAMINOETHANE)CARBAMOYL]CHOLESTEROL; AMINE; AMINO ACID DERIVATIVE; CARBOXYLIC ACID; CHOLESTEROL DERIVATIVE; GLUTAMIC ACID; LIPOFECTAMINE; LIPOSOME; MESSENGER RNA; N,N'' DIOLEYLGLUTAMIDE; OLEYLAMINE; RED FLUORESCENT PROTEIN; SMALL INTERFERING RNA; SURVIVIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CHEMICAL BOND; COMPLEX FORMATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL GENE DELIVERY SYSTEM; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SOLID TUMOR; SYNTHESIS;

AMINO ACIDS; ANIMALS; CATIONS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; CHROMATOGRAPHY, GEL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ELECTROCHEMISTRY; GENE SILENCING; GLUTAMINE; HUMANS; LIPIDS; LIPOPEPTIDES; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 70450223718     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.06.017     Document Type: Article

References (29)

1. de Fougerolles A., Vornlocher H.P., Maraganore J., and Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat. Rev. Drug Discov. 6 (2007) 443-453
2. Kim D., and Rossi J. RNAi mechanisms and applications. Biotechniques 44 (2008) 613-616
3. Hokaiwado N., Takeshita F., Banas A., and Ochiya T. RNAi-based drug discovery and its application to therapeutics. IDrugs 11 (2008) 274-278
4. Xie F.Y., Woodle M.C., and Lu P.Y. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development. Drug Discov. Today 11 (2006) 67-73
5. Nguyen T., Menocal E.M., Harborth J., and Fruehauf J.H. RNAi therapeutics: an update on delivery. Curr. Opin. Mol. Ther. 10 (2008) 158-167
6. Kim H.R., Kim I.K., Bae K.H., Lee S.H., Lee Y., and Park T.G. Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA. Mol. Pharmacol. 5 (2008) 622-631
7. Liu X., Howard K.A., Dong M., Andersen M.Ø., Rahbek U.L., Johnsen M.G., Hansen O.C., Besenbacher F., and Kjems J. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 28 (2007) 1280-1288
8. Patil M.L., Zhang M., Betigeri S., Taratula O., He H., and Minko T. Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. Bioconjug. Chem. 19 (2008) 1396-1403
9. Jere D., Xu C.X., Arote R., Yun C.H., Cho M.H., and Cho C.S. Poly(beta-amino ester) as a carrier for si/shRNA delivery in lung cancer cells. Biomaterials 29 (2008) 2535-2547
10. Meade B.R., and Dowdy S.F. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv. Drug Deliv. Rev. 60 (2008) 530-536
11. Rao N.M., and Gopal V. Cell biological and biophysical aspects of lipid-mediated gene delivery. Biosci. Rep. 26 (2006) 301-324
12. Han S.E., Kang H., Shim G.Y., Suh M.S., Kim S.J., Kim J.S., and Oh Y.K. Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA. Int. J. Pharm. 353 (2008) 260-269
13. Yadava P., Roura D., and Hughes J.A. Evaluation of two cationic delivery systems for siRNA. Oligonucleotides 17 (2007) 213-222
14. Zhang S., Xu Y., Wang B., Qiao W., Liu D., and Li Z. Cationic compounds used in lipoplexes and polyplexes for gene delivery. J. Control. Release 100 (2004) 165-180
15. Zhang S., Zhao B., Jiang H., Wang B., and Ma B. Cationic lipids and polymers mediated vectors for delivery of siRNA. J. Control. Release 123 (2007) 1-10
16. Lv H., Zhang S., Wang B., Cui S., and Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 114 (2006) 100-109
17. Akinc A., Zumbuehl A., Goldberg M., Leshchiner E.S., Busini V., Hossain N., Bacallado S.A., Nguyen D.N., Fuller J., Alvarez R., Borodovsky A., Borland T., Constien R., de Fougerolles A., Dorkin J.R., Narayanannair Jayaprakash K., Jayaraman M., John M., Koteliansky V., Manoharan M., Nechev L., Qin J., Racie T., Raitcheva D., Rajeev K.G., Sah D.W., Soutschek J., Toudjarska I., Vornlocher H.P., Zimmermann T.S., Langer R., and Anderson D.G. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 26 (2008) 561-569
18. Kim H.S., Song I.H., Kim J.C., Kim E.J., Jang D.O., and Park Y.S. In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD (O,O′-dimyristyl-N-lysyl aspartate) and DMKE (O,O′-dimyristyl-N-lysyl glutamate). J. Control. Release 115 (2006) 234-241
19. Obata Y., Suzuki D., and Takeoka S. Evaluation of cationic assemblies constructed with amino acid based lipids for plasmid DNA delivery. Bioconjug. Chem. 19 (2008) 1055-1063
20. Spagnou S., Miller A.D., and Keller M. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 43 (2004) 13348-13356
21. Oh Y.K., Kim M.Y., Shin J.Y., Kim T.W., Yun M.O., Yang S.J., Choi S.S., Jung W.W., Kim J.A., and Choi H.G. Skin permeation of retinol in Tween 20-based deformable liposomes: in-vitro evaluation in human skin and keratinocyte models. J. Pharm. Pharmacol. 58 (2006) 161-166
22. van der Gun B.T., Monami A., Laarmann S., Raskó T., Slaska-Kiss K., Weinhold E., Wasserkort R., de Leij L.F., Ruiters M.H., Kiss A., and McLaughlin P.M. Serum insensitive, intranuclear protein delivery by the multipurpose cationic lipid SAINT-2. J. Control. Release 123 (2007) 228-238
23. Fletcher S., Ahmad A., Price W.S., Jorgensen M.R., and Miller A.D. Biophysical properties of CDAN/DOPE-analogue lipoplexes account for enhanced gene delivery. Chembiochem 9 (2008) 455-463
24. Congiu A., Pozzi D., Esposito C., Castellano C., and Mossa G. Correlation between structure and transfection efficiency: a study of DC-Chol-DOPE/DNA complexes. Colloids Surf. B Biointerfaces 36 (2004) 43-48
25. Maitani Y., Igarashi S., Sato M., and Hattori Y. Cationic liposome (DC-Chol/DOPE = 1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression. Int. J. Pharm. 342 (2007) 33-39
26. Esposito C., Generosi J., Mossa G., Masotti A., and Castellano A.C. The analysis of serum effects on structure, size and toxicity of DDAB-DOPE and DC-Chol-DOPE lipoplexes contributes to explain their different transfection efficiency. Colloids Surf. B Biointerfaces 53 (2006) 187-192
27. Reynier P., Briane D., Coudert R., Fadda G., Bouchemal N., Bissieres P., Taillandier E., and Cao A. Modifications in the head group and in the spacer of cholesterol-based cationic lipids promote transfection in melanoma B16-F10 cells and tumours. J. Drug Target. 12 (2004) 25-38
28. Sanguino A., Lopez-Berestein G., and Sood A.K. Strategies for in vivo siRNA delivery in cancer. Mini Rev. Med. Chem. 8 (2008) 248-255
29. Futami K., Kumagai E., Makino H., Sato A., Takagi M., Shimamoto A., and Furuichi Y. Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models. Cancer Sci. 99 (2008) 1227-1236